🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

A Post-Market Assessment of the Safety and Performance of the TriClip™ System

Recruitingn/aAges 18 Years - anyAllAbbott Medical Devices
NCT07586995 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The objective of the TREAT TR study is to confirm the safety and performance of the TriClip System for tricuspid TEER in a contemporary, real-world setting, using the commercially available device in accordance with its approved indications for use.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Subject is eligible to receive the TriClip System per the current approved indications for use and is intended to undergo the procedure. 2. Subject, or their legally authorized representative, has provided written informed consent prior to study procedure. 3. Subject agrees to attend follow-up assessments. 4. Subject is ≥ 18 years of age (or legal age of consent) at time of consent. Exclusion Criteria: 1. Subject is participating in another clinical study that could impact the follow-up or results of this study. 2. Subject has an existing TriClip implant 3. Presence of other conditions or factors that, in the Investigator's opinion, could limit the subject's ability to participate in follow-up.
💊

What it tests

  • Tricuspid Transcatheter Edge-to-Edge Repair (TEER)
📍

Where

9 sites
Banner University Medical Center Phoenix
Phoenix, United States
Scripps Health
La Jolla, United States
Northwestern Memorial Hospital
Chicago, United States
Ascension Texas Cardiovascular Research
Austin, United States
Sentara Norfolk General Hospital
Norfolk, United States
St. Johannes Hospital
Dortmund, Germany
Ospedale San Raffaele - Cardiac
Milan, Italy
Hospital Universitario Central de Asturias
Oviedo, Spain

…and 1 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy